Key Findings:  This report concerns a patient who had long-standing diarrhea due to colitis associated with cannabidiol (CBD) use. Once treated and abstained from CBD both resolved.
Type of Study:  Meta-analysis
Study Sample Size:  1
Study Result:  Negative
Research Location(s):  United States
Year of Pub:  2020
Cannabinoids Studied:  Cannabidiol (CBD), Anandamide (AEA), 2-Arachidonoyl Glycerol (2-AG)
Phytocannabinoid Source:  Cannabis Flower derived
Chemotype:  Chemotype III
Receptors Studied:  CB1, CB2, TRPs
Route of Administration:  Oral (Ingestion), Sublingual/Oromucosal
Citation:  Oruganti P, et al. Cannabidiol Oil-Associated Microscopic Colitis. Cureus. 2020; 12:e10528. doi: 10.7759/cureus.10528
Authors:  Oruganti P, Betcher S, Wakade Z, Ding X, Abegunde AT